Mechanism of bile salt vasoactivity: dependence on calcium channels in vascular smooth muscle

Jung‐Min ‐M Pak, Ayotunde S O Adeagbo, Christopher Triggle, Eldon A. Shaffer, Samuel S. Lee

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

The vasoactive mechanisms of bile salts have been investigated in rat isolated portal venous and superior mesenteric arterial rings and perfused mesentery. The isolated perfused mesentery was precontracted with a selective α1‐adrenoceptor agonist, cirazoline. Incremental doses of tauroursodeoxycholate (TUDC), taurochenodeoxycholate (TCDC) and taurodeoxycholate (TDC) caused a dose‐dependent vasorelaxation. The order of potency of the vasodilator effect was TDC > TCDC > TUDC. The effect of TDC (1.9 × 10−8 −1.9 × 10−6 mol) was examined before and after propranolol (3 μm), tetraethylammonium (5 mM), ouabain (10−5 M), NG‐nitro‐l‐arginine methyl ester (10−4 M) and capsaicin (50 mg kg−1) to block, respectively, β‐adrenoceptors, K+‐channels, Na+, K+‐ATPase, nitric oxide synthase, and primary sensory nerves. The vasodilator effect of TDC was not affected by any of these blocking agents or by denuding vascular endothelium with distilled water. Infusion of TDC (1.9 × 10−8 −1.9 × 10−6 mol) with K+‐free or high K+ (60 mM) physiological salt solution (PSS) did not affect the vasodilator effect of TDC. Contractions induced by KCl (0.01–1.0 M), arginine vasopressin (AVP, 10−10 −10−7 M) or cirazoline (10−7 × 10−5 M) were all inhibited by TDC (300 μm). TDC (10−6 to 10−3 M) also inhibited the basal tension and the development of spontaneous contractions in the isolated portal vein. TDC (300 μm), however, did not affect noradrenaline‐induced phasic contractions elicited in Ca2+‐free PSS by Ca2+ release from intracellular stores. We conclude that TDC inhibits Ca2+ entry through both voltage‐operated and receptor‐operated calcium channels, whereas intracellular Ca2+ release is not affected. 1994 British Pharmacological Society

Original languageEnglish
Pages (from-to)1209-1215
Number of pages7
JournalBritish Journal of Pharmacology
Volume112
Issue number4
DOIs
Publication statusPublished - 1994
Externally publishedYes

Fingerprint

Taurodeoxycholic Acid
Calcium Channels
Bile Acids and Salts
Vascular Smooth Muscle
Taurochenodeoxycholic Acid
Vasodilator Agents
Mesentery
Salts
Tetraethylammonium
Arginine Vasopressin
Capsaicin
Vascular Endothelium
Ouabain
Portal Vein
Vasodilation
Propranolol
Nitric Oxide Synthase
Adrenergic Receptors
Esters

Keywords

  • Bile salts
  • calcium channels
  • cirrhosis
  • haemodynamics
  • splanchnic circulation
  • taurodeoxycholate
  • vascular smooth muscle

ASJC Scopus subject areas

  • Pharmacology

Cite this

Mechanism of bile salt vasoactivity : dependence on calcium channels in vascular smooth muscle. / Pak, Jung‐Min ‐M; Adeagbo, Ayotunde S O; Triggle, Christopher; Shaffer, Eldon A.; Lee, Samuel S.

In: British Journal of Pharmacology, Vol. 112, No. 4, 1994, p. 1209-1215.

Research output: Contribution to journalArticle

Pak, Jung‐Min ‐M ; Adeagbo, Ayotunde S O ; Triggle, Christopher ; Shaffer, Eldon A. ; Lee, Samuel S. / Mechanism of bile salt vasoactivity : dependence on calcium channels in vascular smooth muscle. In: British Journal of Pharmacology. 1994 ; Vol. 112, No. 4. pp. 1209-1215.
@article{f4a34bb105db49b9b3e9b8e55c823883,
title = "Mechanism of bile salt vasoactivity: dependence on calcium channels in vascular smooth muscle",
abstract = "The vasoactive mechanisms of bile salts have been investigated in rat isolated portal venous and superior mesenteric arterial rings and perfused mesentery. The isolated perfused mesentery was precontracted with a selective α1‐adrenoceptor agonist, cirazoline. Incremental doses of tauroursodeoxycholate (TUDC), taurochenodeoxycholate (TCDC) and taurodeoxycholate (TDC) caused a dose‐dependent vasorelaxation. The order of potency of the vasodilator effect was TDC > TCDC > TUDC. The effect of TDC (1.9 × 10−8 −1.9 × 10−6 mol) was examined before and after propranolol (3 μm), tetraethylammonium (5 mM), ouabain (10−5 M), NG‐nitro‐l‐arginine methyl ester (10−4 M) and capsaicin (50 mg kg−1) to block, respectively, β‐adrenoceptors, K+‐channels, Na+, K+‐ATPase, nitric oxide synthase, and primary sensory nerves. The vasodilator effect of TDC was not affected by any of these blocking agents or by denuding vascular endothelium with distilled water. Infusion of TDC (1.9 × 10−8 −1.9 × 10−6 mol) with K+‐free or high K+ (60 mM) physiological salt solution (PSS) did not affect the vasodilator effect of TDC. Contractions induced by KCl (0.01–1.0 M), arginine vasopressin (AVP, 10−10 −10−7 M) or cirazoline (10−7 × 10−5 M) were all inhibited by TDC (300 μm). TDC (10−6 to 10−3 M) also inhibited the basal tension and the development of spontaneous contractions in the isolated portal vein. TDC (300 μm), however, did not affect noradrenaline‐induced phasic contractions elicited in Ca2+‐free PSS by Ca2+ release from intracellular stores. We conclude that TDC inhibits Ca2+ entry through both voltage‐operated and receptor‐operated calcium channels, whereas intracellular Ca2+ release is not affected. 1994 British Pharmacological Society",
keywords = "Bile salts, calcium channels, cirrhosis, haemodynamics, splanchnic circulation, taurodeoxycholate, vascular smooth muscle",
author = "Pak, {Jung‐Min ‐M} and Adeagbo, {Ayotunde S O} and Christopher Triggle and Shaffer, {Eldon A.} and Lee, {Samuel S.}",
year = "1994",
doi = "10.1111/j.1476-5381.1994.tb13212.x",
language = "English",
volume = "112",
pages = "1209--1215",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Mechanism of bile salt vasoactivity

T2 - dependence on calcium channels in vascular smooth muscle

AU - Pak, Jung‐Min ‐M

AU - Adeagbo, Ayotunde S O

AU - Triggle, Christopher

AU - Shaffer, Eldon A.

AU - Lee, Samuel S.

PY - 1994

Y1 - 1994

N2 - The vasoactive mechanisms of bile salts have been investigated in rat isolated portal venous and superior mesenteric arterial rings and perfused mesentery. The isolated perfused mesentery was precontracted with a selective α1‐adrenoceptor agonist, cirazoline. Incremental doses of tauroursodeoxycholate (TUDC), taurochenodeoxycholate (TCDC) and taurodeoxycholate (TDC) caused a dose‐dependent vasorelaxation. The order of potency of the vasodilator effect was TDC > TCDC > TUDC. The effect of TDC (1.9 × 10−8 −1.9 × 10−6 mol) was examined before and after propranolol (3 μm), tetraethylammonium (5 mM), ouabain (10−5 M), NG‐nitro‐l‐arginine methyl ester (10−4 M) and capsaicin (50 mg kg−1) to block, respectively, β‐adrenoceptors, K+‐channels, Na+, K+‐ATPase, nitric oxide synthase, and primary sensory nerves. The vasodilator effect of TDC was not affected by any of these blocking agents or by denuding vascular endothelium with distilled water. Infusion of TDC (1.9 × 10−8 −1.9 × 10−6 mol) with K+‐free or high K+ (60 mM) physiological salt solution (PSS) did not affect the vasodilator effect of TDC. Contractions induced by KCl (0.01–1.0 M), arginine vasopressin (AVP, 10−10 −10−7 M) or cirazoline (10−7 × 10−5 M) were all inhibited by TDC (300 μm). TDC (10−6 to 10−3 M) also inhibited the basal tension and the development of spontaneous contractions in the isolated portal vein. TDC (300 μm), however, did not affect noradrenaline‐induced phasic contractions elicited in Ca2+‐free PSS by Ca2+ release from intracellular stores. We conclude that TDC inhibits Ca2+ entry through both voltage‐operated and receptor‐operated calcium channels, whereas intracellular Ca2+ release is not affected. 1994 British Pharmacological Society

AB - The vasoactive mechanisms of bile salts have been investigated in rat isolated portal venous and superior mesenteric arterial rings and perfused mesentery. The isolated perfused mesentery was precontracted with a selective α1‐adrenoceptor agonist, cirazoline. Incremental doses of tauroursodeoxycholate (TUDC), taurochenodeoxycholate (TCDC) and taurodeoxycholate (TDC) caused a dose‐dependent vasorelaxation. The order of potency of the vasodilator effect was TDC > TCDC > TUDC. The effect of TDC (1.9 × 10−8 −1.9 × 10−6 mol) was examined before and after propranolol (3 μm), tetraethylammonium (5 mM), ouabain (10−5 M), NG‐nitro‐l‐arginine methyl ester (10−4 M) and capsaicin (50 mg kg−1) to block, respectively, β‐adrenoceptors, K+‐channels, Na+, K+‐ATPase, nitric oxide synthase, and primary sensory nerves. The vasodilator effect of TDC was not affected by any of these blocking agents or by denuding vascular endothelium with distilled water. Infusion of TDC (1.9 × 10−8 −1.9 × 10−6 mol) with K+‐free or high K+ (60 mM) physiological salt solution (PSS) did not affect the vasodilator effect of TDC. Contractions induced by KCl (0.01–1.0 M), arginine vasopressin (AVP, 10−10 −10−7 M) or cirazoline (10−7 × 10−5 M) were all inhibited by TDC (300 μm). TDC (10−6 to 10−3 M) also inhibited the basal tension and the development of spontaneous contractions in the isolated portal vein. TDC (300 μm), however, did not affect noradrenaline‐induced phasic contractions elicited in Ca2+‐free PSS by Ca2+ release from intracellular stores. We conclude that TDC inhibits Ca2+ entry through both voltage‐operated and receptor‐operated calcium channels, whereas intracellular Ca2+ release is not affected. 1994 British Pharmacological Society

KW - Bile salts

KW - calcium channels

KW - cirrhosis

KW - haemodynamics

KW - splanchnic circulation

KW - taurodeoxycholate

KW - vascular smooth muscle

UR - http://www.scopus.com/inward/record.url?scp=0028023275&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028023275&partnerID=8YFLogxK

U2 - 10.1111/j.1476-5381.1994.tb13212.x

DO - 10.1111/j.1476-5381.1994.tb13212.x

M3 - Article

C2 - 7952883

AN - SCOPUS:0028023275

VL - 112

SP - 1209

EP - 1215

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 4

ER -